The Primary Endpoint of Statistically Significant Combined Stage III-IV Reduction Was Not Met, However A Favorable Trend Was Observed Over Time GRAIL Announces U.S. Sales Force Expansion Based on ...

A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across ...

Insulin resistance - when the body doesn't properly respond to insulin, a hormone that helps control blood glucose levels - ...

BIOPREVENT’ AI tool predicts transplant-related immune conflict and mortality risk using biomarkers, helping doctors ...

Khaberni - Early cancer detection technologies are undergoing a radical transformation with the emergence of multicancer blood tests (MCED), which rely on the analysis of free DNA ...

MENLO PARK, Calif., Feb. 19, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial ...

Hyderabad: Cancer research is currently undergoing a massive paradigm shift. Once thought to be triggered by a single genetic ...

CCNSB researchers at IIIT Hyderabad focus on genomics, epigenetics and AI for cancer detection and treatment: Our Bureau, Bengaluru Monday, February 16, 2026, 15:50 Hrs [IST] Rese ...

Hyderabad are advancing cancer research by integrating genomics, epigenetics, gene regulation and artificial intelligence to ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the fourth quarter and full year ...

A powerful artificial intelligence (AI) tool could give clinicians a head start in identifying life-threatening complications after stem cell and bone marrow transplants, according to new research ...